Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

taVNS reduces vitiligo symptoms in mice.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Early intervention and patient education are crucial for managing alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Inflammation affects hair loss; anti-inflammatory treatments may help.

Hair loss treatment caused more hair loss in a man.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Mast cells might contribute to hair loss by causing skin thickening.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.